Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1993-3-19
|
pubmed:abstractText |
The efficacy of intravenous metoprolol in preventing symptoms during a repeat tilt test was compared with the outcome of chronic oral treatment in 21 patients (14 female, 7 male), age 8 to 20 years (mean 13 +/- 3) with unexplained syncope (> or = 1 episode) and a positive response to tilt testing. A positive response was defined as the development of either syncope or presyncope. During the initial tilt test, a positive response occurred during baseline (14 patients) or isoproterenol (0.03 to 0.1 microgram/kg/min) infusion (7 patients) with a cardioinhibitory (1 patient), vasodepressor (5 patients) or mixed (15 patients) pattern. Metoprolol (0.1 to 0.2 mg/kg) was administered intravenously. During the repeat tilt test, response was negative in 18 patients, including 11 of 14 patients with a positive response in the baseline and 7 of 7 patients with a positive response during isoproterenol infusion. Metoprolol (0.8 to 2.8 mg/kg/day) was administered orally to 15 patients for an average of 10 months. Symptoms were absent (7 patients) or improved (2 patients); metoprolol was discontinued because of adverse effects (3 patients) or recurrence of symptoms (3 patients). In 7 of 12 patients with a negative response and 2 of 3 patients with a positive response after intravenous metoprolol, oral administration of metoprolol prevented or improved symptoms without adverse effects. Many young patients (60%) with recurrent syncope obtained symptomatic improvement from chronic oral metoprolol treatment without adverse effects; repeat tilt testing after intravenous metoprolol did not appear to offer any additional information than would have been obtained from a trial of chronic oral treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-9149
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
592-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8438747-Administration, Oral,
pubmed-meshheading:8438747-Adolescent,
pubmed-meshheading:8438747-Adult,
pubmed-meshheading:8438747-Child,
pubmed-meshheading:8438747-Female,
pubmed-meshheading:8438747-Follow-Up Studies,
pubmed-meshheading:8438747-Humans,
pubmed-meshheading:8438747-Injections, Intravenous,
pubmed-meshheading:8438747-Male,
pubmed-meshheading:8438747-Metoprolol,
pubmed-meshheading:8438747-Posture,
pubmed-meshheading:8438747-Syncope
|
pubmed:year |
1993
|
pubmed:articleTitle |
Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons.
|
pubmed:affiliation |
Division of Cardiology, Children's Memorial Hospital, Chicago, Illinois.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|